Novartis AG
Status: Publicly traded
Direct answer
Novartis AG is publicly traded on NYSE under the ticker NVS.
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is...
Can you invest in Novartis AG?
Yes. Novartis AG trades publicly on NYSE as NVS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.